Zimmer Biomet to acquire Monogram Technologies for $177M - The Robot Report

Zimmer Biomet Holdings, a global medical technology company, announced its acquisition of Monogram Technologies, an orthopedic robotics firm, for $177 million. Monogram specializes in combining 3D printing, advanced machine vision, AI, and next-generation robotics, with a focus on semi- and fully autonomous robotic technologies for total knee arthroplasty (TKA). Their CT-based, AI-navigated mBôs system received FDA clearance in March 2025 and is expected to be commercialized with Zimmer Biomet implants by early 2027. Monogram is also developing a fully autonomous version of this technology, which aims to improve safety, efficiency, and surgical outcomes. The acquisition will integrate Monogram’s technology into Zimmer Biomet’s existing ROSA platform, which currently supports multiple orthopedic applications including knee and shoulder replacements. Zimmer Biomet expects this deal to enhance its surgical robotics portfolio by adding advanced semi- and fully autonomous capabilities, thereby broadening its product range and increasing market share, particularly in